Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance

Accelerator-supported research suggests engineered sacs called ARMMs may be uniquely suited to send therapeutics directly to affected areas of the body

Industry veteran named as faculty chair of HBS program that complements Harvard's Blavatnik Biomedical Accelerator

Disrupting an omega-3 fatty acid transporter could open blood-brain barrier for drug delivery